The Oxford Handbook of Philosophy of Imagination and Creativity
March 27, 2026
Andrea Blomkvist
Abstract Abstract This chapter focuses on the role of the imagination in creativity, using aphantasia as a case study. It first distinguishes between imagination and mental imagery, before giving an overview of what we know about aphantasia to date, focusing in particular on findings pertaining to creativity, imagination, and memory. It then turns to the role of the imagination in creativity,...
Psychopathology
March 27, 2026
Xiaoran Ding, Yaping Wu, Juan Yang et al.
1 citation
Ketamine has emerged as a promising rapid-acting antidepressant with distinct advantages for the treatment of treatment-resistant depression (TRD). Its therapeutic effects are mediated through multi-target modulation of the glutamatergic system. Unlike conventional antidepressants, ketamine exerts a markedly faster onset of action; however, its long-term safety profile and potential risk of...
Zenodo (CERN European Organization for Nuclear Research)
March 25, 2026
Stanley Everett Sambey
preprint
Psychedelic experiences are frequently described as producing a “psychological reset,”characterized by reduced rigidity of thought and disruption of maladaptive cognitive pat-terns. Existing models such as REBUS and the entropic brain hypothesis explain acutedestabilization but do not fully account for post-experience reconstruction. This paper pro-poses a two-stage mechanism: (1) constraint...
Aberystwyth Research portal
March 20, 2026
In this creative practice-based project, I explore ways of attending to the unconscious for writing poetry. My dissertation consists of a poetry collection, ‘Hive Mind’, and critical commentary, ‘Listen to the River: attending to the unconscious for poetic production’. I chose the metaphor of listening to the river because my writing process feels like paying attention to something outside of...
PLoS One
March 20, 2026
Katherine G Jones, Marlee M Vandewouw, Jitendra Awasthi et al.
Borderline personality disorder (BPD) is a severe psychiatric condition associated with high rates of suicide and poor interpersonal functioning. There are no FDA-approved medications, and evidence-based psychotherapies such as dialectical behavior therapy (DBT) are difficult to access and vulnerable to patient dropout. Novel treatment directions are urgently needed. Mindfulness is the core...
Brain Sciences
March 14, 2026
Shannon M O'Donnell, W Jack Rejeski, Mohammadreza Khodaei et al.
Previous research has found that mindfulness-based techniques are beneficial for reducing stress in heavy-drinking individuals. However, the underlying neurobiology of these stress-reducing effects are unclear. Moreover, much of the research examining neurobiological correlates of mindfulness has used static functional connectivity, suggesting that brain activity goes unchanged for the entire...
bioRxiv
March 13, 2026
Brian Lord, Erica N. Lord, Jessica N. Schachtner et al.
preprint
Systematic focus training is increasingly recognized for its therapeutic benefits, with equanimity, the ability to maintain an open and accepting attitude towards all experience, identified as a critical mechanism for improving well-being. Physiologically, experienced meditators demonstrate reduced activity in the posterior cingulate cortex (PCC), a hub of the default mode network (DMN), and...
Schizophrenia Research
March 13, 2026
Michel Sabé, Paul Grof, Nathan Sackett et al.
1 citation
Serotonergic psychedelics are re-emerging as therapeutic candidates across psychiatry, particularly for treatment-resistant depression. Their rapid and sustained antidepressant effects, alongside evidence for neuroplastic, dopaminergic, and glutamatergic modulation, have prompted interest in whether they could address depressive and negative symptoms in schizophrenia spectrum disorders (SSDs)....
CNS Spectrums
March 10, 2026
Halima Faisal, Gia Han Le, Angela T H Kwan et al.
Background: Anhedonia and reward-processing deficits are core features of major depressive disorder (MDD) that respond poorly to traditional antidepressants.Ketamine has rapid antidepressant effects, yet its neurofunctional actions within reward circuits remain unclear.We synthesized human neuroimaging evidence on ketamine-related modulation of reward circuitry and implications for...
Discover Mental Health
March 7, 2026
Nicholas Fabiano, Brendon Stubbs, David W. Lawrence et al.
Upwards of 50% of people do not respond to the primary treatment modalities for major depressive disorder (MDD), which has led to increased attention and use of alternative methods, including exercise and psychedelics. While interventions using either exercise or psychedelics have demonstrated largely positive results in isolation, their synergistic potential has yet to be explored. As such,...